Article
The mitochondrial genome as a modifier of autism versus cancer phenotypes in PTEN hamartoma tumor syndrome.
HGG advances - 13 Jul 2023
Wei Ruipeng, Yehia Lamis, Ni Ying, Eng Charis
Abstract excerpt
Cancer and autism spectrum disorder/developmental delay (ASD/DD) are two common clinical phenotypes in individuals with germline PTEN variants (PTEN hamartoma tumor syndrome, PHTS). Burgeoning studies have shown that genomic and metabolomic factors may act as modifiers of ASD/DD versus cancer in PHTS. Recently, we showed copy number variations to be associated with ASD/DD versus cancer in these PHTS individuals....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
